Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- DAWSON A. M., SHERLOCK S., SUMMERSKILL W. H. The treatment and prognosis of hepatic coma. Lancet. 1956 Oct 6;271(6945):689–694. doi: 10.1016/s0140-6736(56)92383-2. [DOI] [PubMed] [Google Scholar]
- KERR D. N., READ A. E., HASLAM R. M., SHERLOCK S. The use of a steroidal spirolactone in the treatment of ascites in hepatic cirrhosis. Lancet. 1958 Nov 22;2(7056):1084–1087. doi: 10.1016/s0140-6736(58)92464-4. [DOI] [PubMed] [Google Scholar]
- LIDDLE G. W. Aldosterone antagonists. AMA Arch Intern Med. 1958 Dec;102(6):998–1004. doi: 10.1001/archinte.1958.00260230144018. [DOI] [PubMed] [Google Scholar]
- READ A. E., HASLAM R. M., LAIDLAW J., SHERLOCK S. Chlorothiazide in control of ascites in hepatic cirrhosis. Br Med J. 1958 Apr 26;1(5077):963–966. doi: 10.1136/bmj.1.5077.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SHALDON S., McLAREN J. R., SHERLOCK S. Resistant ascites treated by combined diuretic therapy (spironolactone, mannitol, and chlorothiazide). Lancet. 1960 Mar 19;1(7125):609–613. doi: 10.1016/s0140-6736(60)90500-6. [DOI] [PubMed] [Google Scholar]
- SLATER J. D., MOXHAM A., HURTER R., NABARRO J. D. Clinical and metabolic effects of aldosterone antagonism. Lancet. 1959 Nov 28;2(7109):931–934. doi: 10.1016/s0140-6736(59)91584-3. [DOI] [PubMed] [Google Scholar]